Literature DB >> 18682393

MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript.

Lingyin Zhou1, Xiaoping Qi, Judith A Potashkin, Fadi W Abdul-Karim, George I Gorodeski.   

Abstract

The P2X7 receptor regulates cell growth through mediation of apoptosis. P2X7 levels are lower in cancer epithelial cells than in normal cells, and previous studies showed that expression of P2X7 was regulated post-transcriptionally. The objective of the study was to understand regulation of P2X7 mRNA stability. Overexpression of a reporter containing the full-length human P2X7 3'-untranslated region (3'-UTR) or reporters containing parts of the 3'-UTR-P2X7 were associated with increased abundance of the construct in normal cells and decreased abundance in cancer epithelial cells. Sequences within the 3'-UTR-P2X7, which are putative target sites for the microRNAs, miR-186 (middle segment) and miR-150 (distal segment), decreased the abundance of the P2X7 transcript. Overexpression in cancer cells of mutated miR-186 and miR-150 target sites was associated with lower levels of the reporter genes. In normal cells overexpression of the mutated miR-186 target site was associated with marked increased concentration, but overexpression of the miR-150 target site reporters, wild-type and mutant, did not change over time. Levels of miR-186 and miR-150 were higher in cancer than in normal cells, and treatment with miR-186 and miR-150 inhibitors increased P2X7 mRNA. In human embryonic kidney-293 cells heterologously expressing the full-length 3'-UTR-P2X7 luciferase reporter, miR-186 and miR-150 inhibitors increased luciferase activity, whereas miR-186 and miR-150 mimics decreased luciferase activity after actinomycin D treatment. These data suggest that increased expression of miR-186 and miR-150 in cancer epithelial cells decreases P2X7 mRNA by activation of miR-186 and miR-150 instability target sites located at the 3'-UTR-P2X7.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682393      PMCID: PMC2568908          DOI: 10.1074/jbc.M802663200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  The widespread impact of mammalian MicroRNAs on mRNA repression and evolution.

Authors:  Kyle Kai-How Farh; Andrew Grimson; Calvin Jan; Benjamin P Lewis; Wendy K Johnston; Lee P Lim; Christopher B Burge; David P Bartel
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

Review 3.  MicroRNA: past and present.

Authors:  Yang Wang; Heidi M Stricker; Deming Gou; Lin Liu
Journal:  Front Biosci       Date:  2007-01-01

4.  Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.

Authors:  Valerio Fulci; Sabina Chiaretti; Marina Goldoni; Gianluca Azzalin; Nicoletta Carucci; Simona Tavolaro; Leandro Castellano; Armando Magrelli; Franca Citarella; Monica Messina; Roberta Maggio; Nadia Peragine; Simona Santangelo; Francesca Romana Mauro; Pablo Landgraf; Thomas Tuschl; David B Weir; Minchen Chien; James J Russo; Jingyue Ju; Robert Sheridan; Chris Sander; Mihaela Zavolan; Anna Guarini; Robin Foà; Giuseppe Macino
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

5.  miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely.

Authors:  Beiyan Zhou; Stephanie Wang; Christine Mayr; David P Bartel; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

Review 6.  The DNA damage response, immunity and cancer.

Authors:  Stephan Gasser; David Raulet
Journal:  Semin Cancer Biol       Date:  2006-07-07       Impact factor: 15.707

Review 7.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 8.  MicroRNA-cancer connection: the beginning of a new tale.

Authors:  George Adrian Calin; Carlo Maria Croce
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

Review 9.  Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment.

Authors:  Salvador Rodriguez-Nieto; Boris Zhivotovsky
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

10.  Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells.

Authors:  Xin Li; Xiaoping Qi; Lingyin Zhou; Deborah Catera; Neal S Rote; Judith Potashkin; Fadi W Abdul-Karim; George I Gorodeski
Journal:  Gynecol Oncol       Date:  2007-05-04       Impact factor: 5.482

View more
  55 in total

1.  miR-186 is decreased in aged brain and suppresses BACE1 expression.

Authors:  Jaekwang Kim; Hyejin Yoon; Dah-Eun Chung; Jennifer L Brown; Krystal C Belmonte; Jungsu Kim
Journal:  J Neurochem       Date:  2016-03-30       Impact factor: 5.372

2.  Regulation of lung surfactant secretion by microRNA-150.

Authors:  Tingting Weng; Amarjit Mishra; Yujie Guo; Yang Wang; Lijing Su; Chaoqun Huang; Chunling Zhao; Xiao Xiao; Lin Liu
Journal:  Biochem Biophys Res Commun       Date:  2012-05-14       Impact factor: 3.575

3.  Melanoma MicroRNA signature predicts post-recurrence survival.

Authors:  Miguel F Segura; Ilana Belitskaya-Lévy; Amy E Rose; Jan Zakrzewski; Avital Gaziel; Douglas Hanniford; Farbod Darvishian; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Iman Osman; Eva Hernando
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

Review 4.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 5.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

6.  Role of microRNA-150 in solid tumors.

Authors:  Fang Wang; Xiubao Ren; Xinwei Zhang
Journal:  Oncol Lett       Date:  2015-04-30       Impact factor: 2.967

Review 7.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

8.  CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.

Authors:  Bao-Chun Jiang; De-Li Cao; Xin Zhang; Zhi-Jun Zhang; Li-Na He; Chun-Hua Li; Wen-Wen Zhang; Xiao-Bo Wu; Temugin Berta; Ru-Rong Ji; Yong-Jing Gao
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

9.  MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Sumit Arora; Bin Wang; William E Grizzle; Ajay P Singh
Journal:  Carcinogenesis       Date:  2011-10-07       Impact factor: 4.944

10.  Regulation of P2X(7) gene transcription.

Authors:  Lingyin Zhou; Liping Luo; Xiaoping Qi; Xin Li; George I Gorodeski
Journal:  Purinergic Signal       Date:  2009-07-16       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.